Device Trial Radar · NCT03417869
QuickVue Influenza A + B Test Field Study
Last checked: Nov 19, 2026Latest source record: Mar 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,381
Actual
Start
Feb 16, 2017
Primary completion
Feb 1, 2018
Study completion Feb 1, 2018
Sponsor
- Lead sponsor
- Quidel CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 31, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Demonstrate improved clinical performance of visually read QuickVue Influenza A+B test.
Conditions
- Influenza A, Influenza B
Interventions
QuickVue Influenza A+BDevice
Rapid diagnostic test with IVD, QuickVue Influenza A+B
Primary outcomes
What the sponsor says the trial is designed to measure.
- Influenza Diagnostic test resultTime frame: 10 minutes
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Alliance Urgent Care
Phoenix, Arizona
Twelve Corners Pediatrics
Rochester, New York
Veritas, P.A.
Belton, Texas
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.